Gold, Poly(β-amino ester) Nanoparticles for Small Interfering RNA Delivery

Jae‐Seung Lee, Jordan J. Green, Kevin T. Love, Joel Sunshine, Róbert Langer, Daniel G. Anderson

Nano Letters · 2009 · 276 citations · 37 references

DOIFull text

Open access

TL;DR

RNA therapeutics face a major barrier in safe and effective delivery, limiting their clinical use. This study develops a nanoparticulate delivery system combining inorganic gold particles with biodegradable polycations. Gold nanoparticles were PEGylated, conjugated to ~30 siRNA strands via disulfide linkages, and then coated with end‑modified poly(β‑amino ester)s to promote intracellular uptake. The resulting formulations achieved in‑vitro siRNA delivery levels comparable to or exceeding those of Lipofectamine 2000.

Abstract

The safe and effective delivery of RNA therapeutics remains the major barrier to their broad clinical application. Here we develop a new nanoparticulate delivery system based on inorganic particles and biodegradable polycations. First, gold nanoparticles were modified with the hydrophilic polymer poly(ethylene glycol) (PEG), and then small interfering RNA (siRNA) was conjugated to the nanoparticles via biodegradable disulfide linkages, with ∼30 strands of siRNA per nanoparticle. The particles were then coated with a library of end-modified poly(β-amino ester)s (PBAEs), previously identified as capable of facilitating intracellular DNA delivery. Nanoparticulate formulations developed here facilitate high levels of in vitro siRNA delivery, facilitating delivery as good or better than the commercially available lipid reagent, Lipofectamine 2000.

References

37